CCPM
CLBT icon

Cooper Creek Partners Management’s Cellebrite CLBT Stock Holding History

Cooper Creek Partners Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,395,973
Closed -$43.2M – 113
2025
Q4 		$43.2M Sell
2,395,973
-626,113
-21% -$11.2M 1.95% 17
2025
Q3 		$56M Buy
+3,022,086
New +$47.5M 1.72% 18

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cooper Creek Partners Management's CLBT Position: Q1 2026 in Review

Cooper Creek Partners Management sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 2,395,973 shares — an estimated $43.2M sold.

Cooper Creek Partners Management first reported a position in CLBT in Q3 2025 and held it in 2 quarters. The position peaked at $56M in Q3 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Cooper Creek Partners Management reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Cooper Creek Partners Management sold 2,395,973 Cellebrite shares in Q1 2026, an estimated $43.2M.
  • Cooper Creek Partners Management first reported a position in Cellebrite in Q3 2025 and held it in 2 quarters.
  • Cooper Creek Partners Management's Cellebrite position peaked at $56M in Q3 2025.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Cooper Creek Partners Management's 13F filing for Q1 2026, filed 15 May 2026.